RU2017104902A - Составы лубрикантов - Google Patents
Составы лубрикантов Download PDFInfo
- Publication number
- RU2017104902A RU2017104902A RU2017104902A RU2017104902A RU2017104902A RU 2017104902 A RU2017104902 A RU 2017104902A RU 2017104902 A RU2017104902 A RU 2017104902A RU 2017104902 A RU2017104902 A RU 2017104902A RU 2017104902 A RU2017104902 A RU 2017104902A
- Authority
- RU
- Russia
- Prior art keywords
- lubricant
- amount
- paragraphs
- lubricant according
- present
- Prior art date
Links
- 239000000314 lubricant Substances 0.000 title claims 32
- 239000000203 mixture Substances 0.000 title 1
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 claims 14
- 229920005573 silicon-containing polymer Polymers 0.000 claims 6
- 239000003995 emulsifying agent Substances 0.000 claims 5
- 229940008099 dimethicone Drugs 0.000 claims 4
- 239000004205 dimethyl polysiloxane Substances 0.000 claims 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims 4
- 239000001488 sodium phosphate Substances 0.000 claims 4
- 229910000162 sodium phosphate Inorganic materials 0.000 claims 4
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical group [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 3
- 230000008014 freezing Effects 0.000 claims 3
- 238000007710 freezing Methods 0.000 claims 3
- 239000000391 magnesium silicate Substances 0.000 claims 3
- 229910052919 magnesium silicate Inorganic materials 0.000 claims 3
- 235000019792 magnesium silicate Nutrition 0.000 claims 3
- 238000002103 osmometry Methods 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- 239000004115 Sodium Silicate Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims 2
- 229910052911 sodium silicate Inorganic materials 0.000 claims 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical group [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 238000005461 lubrication Methods 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M129/00—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing oxygen
- C10M129/02—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing oxygen having a carbon chain of less than 30 atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/10—Materials for lubricating medical devices
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2229/00—Organic macromolecular compounds containing atoms of elements not provided for in groups C10M2205/00, C10M2209/00, C10M2213/00, C10M2217/00, C10M2221/00 or C10M2225/00 as ingredients in lubricant compositions
- C10M2229/02—Unspecified siloxanes; Silicones
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10N—INDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS
- C10N2030/00—Specified physical or chemical properties which is improved by the additive characterising the lubricating composition, e.g. multifunctional additives
- C10N2030/04—Detergent property or dispersant property
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10N—INDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS
- C10N2030/00—Specified physical or chemical properties which is improved by the additive characterising the lubricating composition, e.g. multifunctional additives
- C10N2030/16—Antiseptic; (micro) biocidal or bactericidal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Lubricants (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Claims (23)
1. Лубрикант, содержащий гипохлорит; эмульгатор; и силиконовый полимер.
2. Лубрикант по п. 1, дополнительно содержащий буфер.
3. Лубрикант по п. 2, отличающийся тем, что буфер представляет собой фосфат натрия.
4. Лубрикант по любому из пп. 2-3, отличающийся тем, что буфер присутствует в количестве примерно 0,05%, 0,1%, 0,2%, 0,3%, 0,4%, 0,5%, 1%, 1,5%, 2%, 2,5%, 3%, 3,5%, 4%, 4,5%, 5%, 6%, 7%, 10% или 15% масс./об.
5. Лубрикант по любому из пп. 2-4, отличающийся тем, что буфер присутствует в количестве примерно 0,2% масс./об.
6. Лубрикант по любому из пп. 1-5, отличающийся тем, что гипохлорит присутствует в количестве от примерно 50 до примерно 100 ppm.
7. Лубрикант по любому из пп. 1-6, отличающийся тем, что гипохлорит присутствует в количестве примерно 75 ppm.
8. Лубрикант по любому из пп. 1-7, отличающийся тем, что эмульгатор представляет собой силикат магния и натрия.
9. Лубрикант по любому из пп. 1-8, отличающийся тем, что эмульгатор присутствует в количестве примерно 0,05%, 0,1%, 0,2%, 0,3%, 0,4%, 0,5%, 1%, 1,5%, 2%, 2,5%, 3%, 3,5%, 4%, 4,5%, 5%, 6%, 7%, 10% или 15% масс./об.
10. Лубрикант по любому из пп. 1-9, отличающийся тем, что эмульгатор присутствует в количестве примерно 3,25% масс./об.
11. Лубрикант по любому из пп. 1-10, отличающийся тем, что силиконовый полимер представляет собой диметикон.
12. Лубрикант по любому из пп. 1-11, отличающийся тем, что силиконовый полимер присутствует в количестве примерно 0,5%, 1%, 5%, 10%, 15%, 20%, 30%, 40% или 50% масс./об.
13. Лубрикант по любому из пп. 1-12, отличающийся тем, что силиконовый полимер присутствует в количестве примерно 10% масс./об.
14. Лубрикант по любому из пп. 1-13, дополнительно содержащий воду.
15. Лубрикант по любому из пп. 1-14, отличающийся тем, что лубрикант обладает значением осмоляльности, составляющим примерно 10, 15, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 65, 70, 80, 90 или 100 мОсм/кг как измерено при помощи осмометрии с использованием температуры замерзания.
16. Лубрикант по любому из пп. 1-15, отличающийся тем, что лубрикант обладает значением осмоляльности примерно 22 мОсм/кг как измерено при помощи осмометрии с использованием температуры замерзания.
17. Лубрикант по любому из пп. 1-16, отличающийся тем, что лубрикант обладает значением осмоляльности примерно 54 мОсм/кг как измерено при помощи осмометрии с использованием температуры замерзания.
18. Лубрикант по п. 2, отличающийся тем, что гипохлорит содержится в количестве примерно 75 ppm, причем эмульгатор содержит силикат магния и натрия в количестве примерно 3,25% масс./об., причем силиконовый полимер содержит диметикон в количестве примерно 10% масс./об., причем буфер содержит фосфат натрия в количестве примерно 0,2% масс./об. и причем лубрикант дополнительно содержит воду в количестве примерно 61,55% масс./об.
19. Лубрикант, содержащий гипохлорит; силикат магния и натрия; диметикон; и фосфат натрия.
20. Лубрикант по п. 19, отличающийся тем, что гипохлорит присутствует в количестве примерно 75 ppm, силикат магния и натрия присутствует в количестве примерно 3,25% масс./об., диметикон присутствует в количестве примерно 10% масс./об., фосфат натрия присутствует в количестве примерно 0,2% масс./об. и при этом лубрикант дополнительно содержит воду в количестве примерно 61,55% масс./об.
21. Применение лубриканта по любому из пп. 1-20 для повышения комфорта или смазывающего действия.
22. Способ применения лубриканта, включающий обеспечение лубриканта по любому из пп. 1-20 и нанесение лубриканта.
23. Способ получения лубриканта по любому из пп. 1-20, включающий обеспечение раствора гипохлорита и силиконового полимера и смешивание указанных ингредиентов с получением лубриканта.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/158,442 US9474768B1 (en) | 2016-05-18 | 2016-05-18 | Lubricant formulations |
| US15/158442 | 2016-05-18 | ||
| US15/266147 | 2016-09-15 | ||
| US15/266,147 US9833406B1 (en) | 2016-05-18 | 2016-09-15 | Lubricant formulations |
| PCT/US2016/056760 WO2017200565A1 (en) | 2016-05-18 | 2016-10-13 | Lubricant formulations |
| USPCT/US2016/056760 | 2016-10-13 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017104902A true RU2017104902A (ru) | 2018-08-15 |
| RU2017104902A3 RU2017104902A3 (ru) | 2020-03-24 |
| RU2747029C2 RU2747029C2 (ru) | 2021-04-23 |
Family
ID=57136571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017104902A RU2747029C2 (ru) | 2016-05-18 | 2017-02-15 | Составы лубрикантов |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US9474768B1 (ru) |
| JP (2) | JP6464406B2 (ru) |
| KR (1) | KR102649938B1 (ru) |
| CN (1) | CN107397757A (ru) |
| MX (1) | MX369169B (ru) |
| NZ (2) | NZ738113A (ru) |
| RU (1) | RU2747029C2 (ru) |
| TW (2) | TWI674098B (ru) |
| WO (1) | WO2017200565A1 (ru) |
| ZA (1) | ZA201607310B (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2835620C1 (ru) * | 2019-09-12 | 2025-03-03 | Интервет Интернэшнл Б.В. | Комбинированная вакцина для внутрикожного введения |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150099010A1 (en) | 2013-10-07 | 2015-04-09 | Reoxcyn Discoveries Group, Inc | Redox signaling gel formulation |
| WO2017127452A1 (en) | 2016-01-19 | 2017-07-27 | Reoxcyn Discoveries Group, Inc. | Hypochlorite formulations for wound healing |
| US9474768B1 (en) | 2016-05-18 | 2016-10-25 | Reoxcyn Discoveries Group, Inc. | Lubricant formulations |
| US11857674B2 (en) | 2016-05-18 | 2024-01-02 | Reoxcyn, Llc | Lubricant formulations |
| US9833471B1 (en) | 2016-09-15 | 2017-12-05 | Reoxcyn Discoveries Group, Inc. | Hypochlorous acid-based hand sanitizer |
| US20180200165A1 (en) | 2017-01-16 | 2018-07-19 | Reoxcyn Innovation Group, Llc | Dentifrice formulations and methods of oral care |
| CN111032060A (zh) | 2017-06-28 | 2020-04-17 | 科利迪恩公司 | 用于清洁、消毒和/或灭菌的组合物、方法和用途 |
| WO2019070920A1 (en) * | 2017-10-03 | 2019-04-11 | Collidion, Inc. | COMPOSITIONS, METHODS AND USES FOR ENHANCING A ZONE OF SKIN OR HAIR |
| JP6584588B2 (ja) * | 2017-12-22 | 2019-10-02 | レオキシン・エルエルシー | セルライトの治療のための組成物及び方法 |
| US10292911B1 (en) * | 2017-12-22 | 2019-05-21 | Reoxcyn, Llc | Stable redox compositions and methods of use |
| US10828325B2 (en) * | 2017-12-22 | 2020-11-10 | Reoxcyn, Llc | Hypochlorite compositions for the treatment of traumatic brain injury |
| SG11202006664UA (en) | 2018-01-14 | 2020-08-28 | Collidion Inc | Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating |
| US10918663B2 (en) * | 2018-04-03 | 2021-02-16 | Reoxcyn, Llc | Compositions and methods for the treatment of bacterial vaginosis |
| US11602582B2 (en) | 2018-04-10 | 2023-03-14 | Chemsil Silicones, Inc. | Intimate care lubricant compositions and methods for making same |
| CA3167941A1 (en) | 2020-02-14 | 2021-08-19 | Collidion, Inc. | Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating |
Family Cites Families (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1200165A (en) | 1913-10-30 | 1916-10-03 | Charles F Burgess | Method and apparatus for sterilizing. |
| JPS5541210B2 (ru) * | 1974-01-29 | 1980-10-22 | ||
| US4236992A (en) | 1979-08-06 | 1980-12-02 | Themy Constantinos D | High voltage electrolytic cell |
| US4316787A (en) | 1979-08-06 | 1982-02-23 | Themy Constantinos D | High voltage electrolytic cell |
| US4671955A (en) * | 1986-03-31 | 1987-06-09 | Victor Palinczar | Waterproof sunscreen compositions |
| US4983779A (en) * | 1986-07-17 | 1991-01-08 | The Board Of Governors Of Wayne State University | Process for the preparation of vinyl ethers |
| JPS6456188A (en) | 1987-03-11 | 1989-03-03 | Tatsuo Okazaki | Electrolyzer for water |
| GB8807752D0 (en) | 1988-03-31 | 1988-05-05 | Unilever Plc | Bleaching composition |
| US4956184A (en) | 1988-05-06 | 1990-09-11 | Alcide Corporation | Topical treatment of genital herpes lesions |
| US5622848A (en) | 1990-05-23 | 1997-04-22 | Medical Discoveries, Inc. | Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood |
| US5334383A (en) | 1990-05-23 | 1994-08-02 | Medical Discoveries, Inc. | Electrically hydrolyzed salines as in vivo microbicides for treatment of cardiomyopathy and multiple sclerosis |
| ATE197172T1 (de) * | 1993-05-13 | 2000-11-15 | American Cyanamid Co | Wässrige siloxan-beschichtungs-zusammensetzung |
| US6117285A (en) | 1994-08-26 | 2000-09-12 | Medical Discoveries, Inc. | System for carrying out sterilization of equipment |
| US5507932A (en) | 1994-08-26 | 1996-04-16 | Schlumberger Technology Corporation | Apparatus for electrolyzing fluids |
| FR2740777B1 (fr) * | 1995-11-02 | 1998-01-02 | Hutchinson | Films d'elastomere contenant au moins une substance chimique active, leur procede de preparation et leurs applications |
| SG60166A1 (en) * | 1996-12-09 | 1999-02-22 | Becton Dickinson Co | Waterborne lubricant for teflon products |
| EP1043970A1 (en) | 1998-01-06 | 2000-10-18 | The Procter & Gamble Company | Antimicrobial peroxy acid oral care compositions and methods |
| US6114398A (en) | 1998-03-03 | 2000-09-05 | Ratcliff; Perry A. | Personal lubricant to prevent and stop itching |
| GB2355190B (en) | 1999-08-23 | 2004-07-28 | Sterilox Medical | Improvements in or relating to sterilising preparations |
| US6333054B1 (en) | 1999-10-21 | 2001-12-25 | Amuchina S.P.A. | Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| US6589568B2 (en) | 2001-02-16 | 2003-07-08 | Nurad, Inc. | Therapeutic body lotion containing alkali metal hypohalite |
| SE0103766D0 (sv) | 2001-11-09 | 2001-11-09 | Astrazeneca Ab | Novel assay |
| US10117812B2 (en) * | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US20050089537A1 (en) | 2003-10-27 | 2005-04-28 | Birnholz Jason C. | Personal lubricant with silicone polymers |
| GB0328124D0 (en) | 2003-12-04 | 2004-01-07 | Daly James | Membrane electrolyser with a two part end design |
| US20050196462A1 (en) | 2003-12-30 | 2005-09-08 | Oculus Innovative Sciences, Inc. | Topical formulation containing oxidative reductive potential water solution and method for using same |
| US20080003171A1 (en) | 2004-04-20 | 2008-01-03 | Smith William L | Microbial Control Using Hypochlorous Acid Vapor |
| CN101010261B (zh) | 2004-10-08 | 2010-04-07 | 日本科技股份有限公司 | 中性电解水、中性电解水的制造方法及中性电解水的制造装置 |
| EP1829449A4 (en) | 2004-11-24 | 2008-10-08 | Maruishi Pharma | STERILIZATION COMPOSITION BASED ON LOW-CHLORINOUS ACID |
| GB0504547D0 (en) | 2005-03-04 | 2005-04-13 | Delsol Products Ltd | Personal lubricant |
| CA2602522C (en) | 2005-03-23 | 2014-09-09 | Oculus Innovative Sciences, Inc. | Method of treating skin ulcers using oxidative reductive potential water solution |
| US20060241002A1 (en) | 2005-04-26 | 2006-10-26 | Rogozinski Wallace J | Sodium hypochlorite gel composition |
| US8083586B2 (en) | 2005-06-22 | 2011-12-27 | Nokia Corporation | System and method for providing interoperability of independently-operable electronic games |
| US20070172412A1 (en) | 2006-01-26 | 2007-07-26 | Linda Hratko | Thickened fluid composition comprising chlorine dioxide |
| US20090169646A1 (en) | 2006-02-22 | 2009-07-02 | Puricore, Inc. | Methods of treating cystic fibrosis |
| US8673297B2 (en) | 2006-02-28 | 2014-03-18 | Basf Corporation | Chlorine dioxide based cleaner/sanitizer |
| US20070281008A1 (en) | 2006-06-05 | 2007-12-06 | Lin Shun Y | Personal lubricant compositions and kits for providing personal lubrication |
| EP1886664A1 (en) | 2006-08-08 | 2008-02-13 | José Sidnei Pereira | N-chloroamines containing compositions |
| WO2008089268A2 (en) | 2007-01-16 | 2008-07-24 | Puricore, Inc. | Methods and compositions for treating conditions associated with infection and/or inflammation |
| EP2136819A1 (en) | 2007-03-13 | 2009-12-30 | Oculus Innovative Sciences, Inc. | Antimicrobial solutions containing dichlorine monoxide and methods of making and using the same |
| GB0713799D0 (en) | 2007-07-17 | 2007-08-22 | Byotrol Llc | Anti-microbial compositions |
| US20090068122A1 (en) | 2007-09-06 | 2009-03-12 | Shira Pilch | Dentifrice Compositions for Treating Xerostomia |
| US8770201B2 (en) * | 2007-10-26 | 2014-07-08 | Glycobiosciences Inc. | Condom with multifunctional coating |
| US20090148342A1 (en) | 2007-10-29 | 2009-06-11 | Bromberg Steven E | Hypochlorite Technology |
| US20140044800A1 (en) | 2007-10-30 | 2014-02-13 | Daniel Robinson | Stable Reactive Oxygen Composition |
| US9446072B2 (en) | 2007-10-30 | 2016-09-20 | Reoxcyn Discoveries Group, Inc. | Methods of ameliorating oxidative stress by increasing the efficiency of GPX and SOD activity |
| US20150093451A1 (en) | 2007-10-30 | 2015-04-02 | Reoxcyn Discoveries Group, Inc. | Method of increasing energy expenditure |
| US8945630B2 (en) | 2008-04-11 | 2015-02-03 | Aquilabs S.A. | Method of producing and applications of composition of hypochlorous acid |
| JPWO2010004699A1 (ja) | 2008-07-09 | 2011-12-22 | パーフェクトペリオ株式会社 | 口臭抑制剤及びその生成方法 |
| US8518382B2 (en) | 2008-07-15 | 2013-08-27 | Basf Corporation | Tooth polishing compositions and methods of tooth polishing without mechanical abrasion |
| US20100078331A1 (en) | 2008-10-01 | 2010-04-01 | Scherson Daniel A | ELECTROLYTIC DEVICE FOR GENERATION OF pH-CONTROLLED HYPOHALOUS ACID AQUEOUS SOLUTIONS FOR DISINFECTANT APPLICATIONS |
| US20100012132A1 (en) | 2008-11-12 | 2010-01-21 | Chemsil Silicones, Inc. | Clear, washable lubricant compositions, and methods of making same |
| US20100147701A1 (en) | 2008-12-17 | 2010-06-17 | Tennant Company | Method and apparatus for applying electrical charge through a liquid to enhance sanitizing properties |
| US20100184684A1 (en) | 2009-01-06 | 2010-07-22 | C3 Jian, Inc. | Antibacterial and antifungal peptides |
| EP2411021A4 (en) | 2009-03-23 | 2012-09-05 | Kross Link Lab | METHOD FOR SUPPRESSION OR PREVENTION OF FIBROUS ADHESION FORMATION USING MULTI-COMPONENT AQUEOUS OXYCHLORIN COMPOSITION PREPARED ON SITE |
| BR112012006891A2 (pt) | 2009-07-30 | 2019-09-24 | Oculus Innovative Sciences Inc | formulação de hydrogel compreendendo uma solução aquosa com potencial oxidativo redutivo |
| WO2011026094A2 (en) | 2009-08-31 | 2011-03-03 | Collegium Pharmaceutical, Inc. | Stable aerosol topical foams comprising a hypochlorite salt |
| US20110065798A1 (en) * | 2009-09-17 | 2011-03-17 | Becton, Dickinson And Company | Anti-infective lubricant for medical devices and methods for preparing the same |
| US20120046556A1 (en) * | 2010-04-09 | 2012-02-23 | Block Robert M | Methods and Kits for Preventing the Spread of Sexually Transmitted Microorganisms |
| CN103154095A (zh) | 2010-08-05 | 2013-06-12 | 生物膜Ip有限责任公司 | 环硅氧烷取代的聚硅氧烷化合物、包含所述化合物的组合物及其使用方法 |
| US20120148516A1 (en) | 2010-12-10 | 2012-06-14 | Precision Dermatology, Inc. | Tandem Hypochlorite-Barrier Repair Therapy for the Treatment of Eczema |
| CN102167997B (zh) | 2011-03-11 | 2013-06-12 | 刘小清 | 一种不需防腐剂的天然消毒洗涤组合物 |
| MX390111B (es) | 2011-03-18 | 2025-03-19 | Urgo Us Inc | Soluciones estabilizadas de acido hipohaloso. |
| US20130164228A1 (en) | 2011-12-21 | 2013-06-27 | Colgate-Palmolive Company | Compositions comprising gallates and gallamides |
| JP6209169B2 (ja) | 2012-02-20 | 2017-10-04 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | ポリマーを用いた殺生物剤の抗微生物活性の増強 |
| WO2014055621A1 (en) | 2012-10-04 | 2014-04-10 | Church & Dwight Co., Inc. | Non-irritating lubricant compositions with active sensorial agents |
| EP2903623A4 (en) | 2012-10-04 | 2016-03-30 | Church & Dwight Co Inc | PERSONAL AQUEOUS LUBRICANTS WITH A SILICONE COMPONENT |
| US20160143944A1 (en) | 2013-07-01 | 2016-05-26 | Puricoe, Inc. | Antimicrobial compositions comprising hypochlorous acid and silver |
| JP2015016408A (ja) | 2013-07-10 | 2015-01-29 | モレックス インコーポレイテドMolex Incorporated | 酸性電解水およびその製造方法、ならびに該酸性電解水を含む洗浄剤および殺菌剤 |
| US20150099010A1 (en) | 2013-10-07 | 2015-04-09 | Reoxcyn Discoveries Group, Inc | Redox signaling gel formulation |
| WO2015061753A1 (en) | 2013-10-24 | 2015-04-30 | Reoxcyn Discoveries Group, Inc. | Redox signaling gel formulation |
| US20150125543A1 (en) | 2013-11-07 | 2015-05-07 | Simple Science Limited | Gel disinfecting composition |
| CN104922055A (zh) * | 2014-03-19 | 2015-09-23 | 张益寿 | 用于润滑保湿消毒灭菌的半流体组成物及其使用方法 |
| CN104476966A (zh) * | 2014-11-12 | 2015-04-01 | 颍上县陈家工艺家具有限公司 | 基于木质家具镶嵌贝壳拼花的工艺 |
| EP3233091A4 (en) | 2014-12-16 | 2018-07-18 | Realm Therapeutics, Inc. | Hypochlorous acid formulations and methods for treating skin conditions |
| WO2017127452A1 (en) | 2016-01-19 | 2017-07-27 | Reoxcyn Discoveries Group, Inc. | Hypochlorite formulations for wound healing |
| US9474768B1 (en) * | 2016-05-18 | 2016-10-25 | Reoxcyn Discoveries Group, Inc. | Lubricant formulations |
-
2016
- 2016-05-18 US US15/158,442 patent/US9474768B1/en active Active
- 2016-09-15 US US15/266,147 patent/US9833406B1/en active Active
- 2016-10-13 WO PCT/US2016/056760 patent/WO2017200565A1/en not_active Ceased
- 2016-10-19 MX MX2016013744A patent/MX369169B/es active IP Right Grant
- 2016-10-24 ZA ZA2016/07310A patent/ZA201607310B/en unknown
- 2016-10-25 NZ NZ738113A patent/NZ738113A/en unknown
- 2016-10-25 NZ NZ725569A patent/NZ725569A/en unknown
- 2016-10-31 JP JP2016212701A patent/JP6464406B2/ja active Active
-
2017
- 2017-02-15 RU RU2017104902A patent/RU2747029C2/ru active
- 2017-02-17 KR KR1020170021696A patent/KR102649938B1/ko active Active
- 2017-03-06 CN CN201710127546.7A patent/CN107397757A/zh active Pending
- 2017-03-17 TW TW106109008A patent/TWI674098B/zh active
- 2017-03-17 TW TW108102122A patent/TWI674099B/zh active
- 2017-11-20 US US15/818,531 patent/US10471003B2/en active Active
-
2018
- 2018-12-12 JP JP2018232443A patent/JP6821639B2/ja active Active
-
2019
- 2019-11-01 US US16/671,707 patent/US11083689B2/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2835620C1 (ru) * | 2019-09-12 | 2025-03-03 | Интервет Интернэшнл Б.В. | Комбинированная вакцина для внутрикожного введения |
Also Published As
| Publication number | Publication date |
|---|---|
| TWI674098B (zh) | 2019-10-11 |
| KR20170130275A (ko) | 2017-11-28 |
| WO2017200565A1 (en) | 2017-11-23 |
| CN107397757A8 (zh) | 2018-06-19 |
| NZ738113A (en) | 2018-07-27 |
| ZA201607310B (en) | 2020-08-26 |
| NZ725569A (en) | 2018-02-23 |
| KR102649938B1 (ko) | 2024-03-22 |
| US11083689B2 (en) | 2021-08-10 |
| US20200237655A1 (en) | 2020-07-30 |
| MX2016013744A (es) | 2017-11-17 |
| US9833406B1 (en) | 2017-12-05 |
| US10471003B2 (en) | 2019-11-12 |
| TW201919660A (zh) | 2019-06-01 |
| US20180325809A1 (en) | 2018-11-15 |
| JP2017206668A (ja) | 2017-11-24 |
| BR102017003973A2 (pt) | 2017-12-05 |
| RU2017104902A3 (ru) | 2020-03-24 |
| RU2747029C2 (ru) | 2021-04-23 |
| JP6821639B2 (ja) | 2021-01-27 |
| JP6464406B2 (ja) | 2019-02-06 |
| US9474768B1 (en) | 2016-10-25 |
| TW201740956A (zh) | 2017-12-01 |
| JP2019059950A (ja) | 2019-04-18 |
| TWI674099B (zh) | 2019-10-11 |
| US20170333343A1 (en) | 2017-11-23 |
| CN107397757A (zh) | 2017-11-28 |
| MX369169B (es) | 2019-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017104902A (ru) | Составы лубрикантов | |
| MX2018006919A (es) | Composiciones de emulsion inversas. | |
| RU2015141767A (ru) | Композиции и способы для местной доставки простагландинов в подкожный жир | |
| JP2014139241A5 (ru) | ||
| RU2020123688A (ru) | Композиции средств личной гигиены и способы стабилизации микробиома | |
| EA201591302A1 (ru) | Некариесогенное желейное кондитерское изделие | |
| EA201591067A1 (ru) | Неводные композиции для ухода за полостью рта | |
| MY194702A (en) | Liquid skin cleansing agent composition | |
| EA201891485A1 (ru) | Композиция зубной пасты | |
| WO2019123261A3 (en) | Oral compositions and methods of use | |
| MX2015012784A (es) | Composiciones suavizantes de telas. | |
| CL2017001860A1 (es) | Agente espumante para usar en la preparación de coberturas comestibles y un método para la preparación de dicho agente. | |
| RU2013146037A (ru) | Косметическая композиция в виде эмульсии вода-в-масле | |
| BR112018006343A2 (pt) | composição de gordura de safa reduzidos, e, emulsão aerada | |
| IN2014MN00929A (ru) | ||
| MX366176B (es) | Limpiador liquido para la piel. | |
| RU2017103432A (ru) | Состав для обесцвечивания волос | |
| RU2017133254A (ru) | Композиции, содержащие комбинации органических кислот | |
| RU2013146038A (ru) | Косметическая композиция в виде эмульсии вода-в-масле | |
| RU2017129694A (ru) | Смазочная композиция | |
| FR3027236B1 (fr) | Emulsion aqueuse de peroxyde de dialkyle | |
| PH22019500018U3 (en) | Nanoemulsions with color stabilized actives | |
| RU2017134731A (ru) | Ионоактивный водный раствор на основе растворенных неорганических солей, предпочтительно предназначенный для ухода за горлом | |
| MX381831B (es) | Composiciones lácteas espumantes. | |
| MX2016002714A (es) | Composicion y metodo para tropicalizar chocolate. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HZ9A | Changing address for correspondence with an applicant |